Clinical Trial Update: Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cyclophosphamide, paclitaxel, and trastuzumab in patients with stage I to II HER2-positive breast cancer after surgery has completed. R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• PACLITAXEL (PACLITAXEL)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: University of Nebraska | Conditions: HER2 Positive Breast Carcinoma, Stage I Breast Cancer AJCC v7 | Phase 2 | Status: COMPLETED | Results posted: 2026-03-23